Headline Details
Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion
Published on: Sat, 12 Dec 2020 18:39:42 UTCNews Agency: CNN
Description:
Leading Covid-19 vaccine developer AstraZeneca agreed on Saturday to buy Boston pharmaceutical firm Alexion for $39 billion.
Click here for FULL Story on CNN